Regions Financial Corp’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.55M Sell
124,432
-4,510
-3% -$263K 0.05% 185
2025
Q4
$6.96M Sell
128,942
-8,068
-6% -$388K 0.04% 192
2025
Q3
$6.18M Sell
137,010
-9,670
-7% -$452K 0.04% 203
2025
Q2
$6.79M Sell
146,680
-7,997
-5% -$393K 0.05% 196
2025
Q1
$9.43M Sell
154,677
-4,851
-3% -$283K 0.07% 157
2024
Q4
$9.02M Sell
159,528
-10,355
-6% -$579K 0.07% 166
2024
Q3
$8.79M Sell
169,883
-11,294
-6% -$530K 0.06% 169
2024
Q2
$7.52M Sell
181,177
-50,630
-22% -$2.27M 0.06% 177
2024
Q1
$12.6M Sell
231,807
-19,875
-8% -$1.01M 0.1% 151
2023
Q4
$12.9M Sell
251,682
-23,977
-9% -$1.26M 0.11% 147
2023
Q3
$16M Sell
275,659
-30,078
-10% -$1.84M 0.14% 128
2023
Q2
$19.6M Sell
305,737
-63,560
-17% -$4.26M 0.17% 120
2023
Q1
$25.6M Sell
369,297
-413,473
-53% -$29.2M 0.23% 107
2022
Q4
$56.3M Sell
782,770
-19,907
-2% -$1.5M 0.52% 58
2022
Q3
$57.1M Sell
802,677
-4,876
-0.6% -$354K 0.58% 51
2022
Q2
$62.2M Sell
807,553
-37,870
-4% -$2.88M 0.59% 48
2022
Q1
$61.7M Buy
845,423
+184
+0% +$12.4K 0.5% 55
2021
Q4
$52.7M Sell
845,239
-10,115
-1% -$593K 0.41% 71
2021
Q3
$50.6M Sell
855,354
-11,427
-1% -$753K 0.44% 69
2021
Q2
$57.9M Sell
866,781
-4,455
-0.5% -$290K 0.5% 60
2021
Q1
$55M Sell
871,236
-7,008
-0.8% -$436K 0.5% 60
2020
Q4
$54.5M Buy
878,244
+5,586
+0.6% +$343K 0.53% 58
2020
Q3
$52.6M Buy
872,658
+4,221
+0.5% +$254K 0.57% 52
2020
Q2
$51.1M Buy
868,437
+19,249
+2% +$1.15M 0.59% 49
2020
Q1
$47.3M Buy
849,188
+128,520
+18% +$7.86M 0.63% 46
2019
Q4
$46.3M Sell
720,668
-81,387
-10% -$4.66M 0.49% 60
2019
Q3
$40.7M Buy
802,055
+11,424
+1% +$537K 0.45% 68
2019
Q2
$35.9M Buy
790,631
+33,845
+4% +$1.58M 0.4% 78
2019
Q1
$36.1M Buy
756,786
+35,254
+5% +$1.76M 0.42% 78
2018
Q4
$37.5M Sell
721,532
-23,933
-3% -$1.29M 0.47% 68
2018
Q3
$46.3M Sell
745,465
-39,479
-5% -$2.34M 0.5% 62
2018
Q2
$43.4M Sell
784,944
-79,693
-9% -$4.3M 0.49% 65
2018
Q1
$54.7M Buy
864,637
+20,954
+2% +$1.35M 0.61% 55
2017
Q4
$51.7M Buy
843,683
+59,418
+8% +$3.72M 0.56% 61
2017
Q3
$50M Sell
784,265
-10,140
-1% -$592K 0.57% 58
2017
Q2
$44.3M Sell
794,405
-1,026
-0.1% -$55.8K 0.52% 59
2017
Q1
$43.3M Sell
795,431
-167,364
-17% -$9.18M 0.51% 64
2016
Q4
$56.3M Sell
962,795
-39,265
-4% -$2.15M 0.69% 46
2016
Q3
$54M Sell
1,002,060
-124,567
-11% -$8M 0.7% 44
2016
Q2
$82.9M Sell
1,126,627
-14,147
-1% -$1,000K 1.07% 25
2016
Q1
$72.9M Buy
1,140,774
+12,347
+1% +$779K 0.97% 27
2015
Q4
$77.6M Buy
1,128,427
+38,360
+4% +$2.53M 1.04% 26
2015
Q3
$64.5M Buy
1,090,067
+95,764
+10% +$6.08M 0.92% 27
2015
Q2
$66.2M Buy
994,303
+231,949
+30% +$15.3M 0.88% 28
2015
Q1
$49.2M Buy
762,354
+237,734
+45% +$14.9M 0.63% 44
2014
Q4
$31M Buy
524,620
+23,456
+5% +$1.32M 0.4% 85
2014
Q3
$25.6M Sell
501,164
-15,802
-3% -$789K 0.32% 97
2014
Q2
$25.1M Sell
516,966
-17,490
-3% -$862K 0.31% 99
2014
Q1
$27.8M Sell
534,456
-107,226
-17% -$5.71M 0.35% 88
2013
Q4
$34.1M Sell
641,682
-30,143
-4% -$1.54M 0.42% 77
2013
Q3
$31.1M Sell
671,825
-62,076
-8% -$2.72M 0.41% 81
2013
Q2
$32.8M Buy
+733,901
New +$31.9M 0.45% 72

Other funds holding BMY

Regions Financial Corp's BMY Position: Q1 2026 in Review

Regions Financial Corp reduced its Bristol-Myers Squibb (BMY) stake by 3.5% in Q1 2026, selling an estimated $263K and leaving 124,432 shares worth $7.55M. The position accounts for 0.05% of the portfolio, ranked #185.

Regions Financial Corp first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $82.9M in Q2 2016. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Regions Financial Corp held 124,432 shares of Bristol-Myers Squibb worth $7.55M as of Q1 2026.
  • Regions Financial Corp sold 4,510 Bristol-Myers Squibb shares in Q1 2026, an estimated $263K.
  • Bristol-Myers Squibb made up 0.05% of Regions Financial Corp's portfolio in Q1 2026, its #185 holding.
  • Regions Financial Corp first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Regions Financial Corp's Bristol-Myers Squibb position peaked at $82.9M in Q2 2016.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Regions Financial Corp's 13F filing for Q1 2026, filed 5 May 2026.